Microsoft HealthVault announces new partners in health info sharing quest

Share this article:
Microsoft HealthVault announces new partners in health info sharing quest
Microsoft HealthVault announces new partners in health info sharing quest
Microsoft's HealthVault has announced a collaboration deal with communications giant AT&T and computer platform service provider Covisint that will allow patients to share medical information with participating doctors via the Internet.

Through the initiative, AT&T will provide broadband access and a dashboard for physicians to access the healthcare information, while Covisint will provide the underlying software that vets the patient info. Microsoft's HealthVault acts as the online storage system for the patient data.

A news release from the three companies did not indicate how many doctors would initially participate in the program.

The new computer exchange platform will also offer insights on constructing national, state and local health-information exchanges, officials for the companies said, and will provide services such as e-prescribing, clinical messaging and sharing of images such as X-rays, MRIs and CT scans.

Earlier this month, Microsoft announced plans to collaborate with the nation's largest nonprofit health maintenance organization Kaiser Permanente in a pilot project open to Kaiser's 156,000 employees, which will run until November.

If the pilot proves successful, a product linking Kaiser patient information with Microsoft's Health Vault would be offered to Kaiser's members.

Both Microsoft and Google, which offer platforms for electronic health record storage, have previously announced collaborative projects with health providers.

Microsoft's partners have included the Mayo Clinic and NewYork-Presbyterian Hospital. Google's partnerships have involved the Cleveland Clinic and Beth Israel Deaconess Medical Center.
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...